The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer

被引:73
作者
Beard, Jordan A.
Tenga, Alexa
Chen, Taosheng
机构
[1] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA
[2] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN 38163 USA
基金
美国国家卫生研究院;
关键词
Nuclear receptor; NR4A; Nur77; Nurr1; Oncogene; Tumour suppressor; ORPHAN NUCLEAR RECEPTOR; HYPOXIA-INDUCIBLE FACTORS; PROTEIN-KINASE B; CELL-DEATH; NGFI-B; HIF-ALPHA; TRANSCRIPTIONAL ACTIVITY; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATION; PROAPOPTOTIC GENES;
D O I
10.1016/j.cellsig.2014.11.009
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Nuclear receptor (NR) subfamily 4 group A (NR4A) is a family of three highly homologous orphan nuclear receptors that have multiple physiological and pathological roles, including some in cancer. These NRs are reportedly dysregulated in multiple cancer types, with many studies demonstrating pro-oncogenic roles for NR4A1 (Nur77) and NR4A2 (Nurr1). Additionally, NR4A1 and NR4A3 (Nor-1) are described as tumor suppressors in leukemia. The dysregulation and functions of the NR4A members are due to many factors, including transcriptional regulation, protein-protein interactions, and post-translational modifications. These various levels of intracellular regulation result from the signaling cross-talk of the NR4A members with various signaling pathways, many of which are relevant to cancer and likely explain the family members' functions in oncogenesis and tumor suppression. In this review, we discuss the multiple functions of the NR4A receptors in cancer and summarize a growing body of scientific literature that describes the interconnectedness of the NR4A receptors with various oncogene and tumor suppressor pathways. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 166 条
[31]
WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[32]
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism [J].
Engelman, Jeffrey A. ;
Luo, Ji ;
Cantley, Lewis C. .
NATURE REVIEWS GENETICS, 2006, 7 (08) :606-619
[33]
The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells [J].
Filion, C ;
Labelle, Y .
EXPERIMENTAL CELL RESEARCH, 2004, 297 (02) :585-592
[34]
Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma [J].
Filion, Christine ;
Labelle, Yves .
TUMOR BIOLOGY, 2012, 33 (05) :1599-1605
[35]
Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain [J].
Flaig, R ;
Greschik, H ;
Peluso-Iltis, C ;
Moras, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :19250-19258
[36]
Flaus A., 2006, NUCLEIC ACIDS RES, V34, P2887
[37]
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[38]
Mutant p53: one name, many proteins [J].
Freed-Pastor, William A. ;
Prives, Carol .
GENES & DEVELOPMENT, 2012, 26 (12) :1268-1286
[39]
ERK5 is involved in TCR-induced apoptosis through the modification of Nur77 [J].
Fujii, Yasushi ;
Matsuda, Satoshi ;
Takayama, Gensuke ;
Koyasu, Shigeo .
GENES TO CELLS, 2008, 13 (05) :411-419
[40]
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling [J].
Gao, XS ;
Zhang, Y ;
Arrazola, P ;
Hino, O ;
Kobayashi, T ;
Yeung, RS ;
Ru, BG ;
Pan, DJ .
NATURE CELL BIOLOGY, 2002, 4 (09) :699-704